Superficial bladder wall tissue

Superficial bladder wall tissue refers to the outermost layers of the bladder, including the urothelium (transitional epithelium) and underlying submucosa, which form a protective barrier against urine while allowing bladder expansion and contraction. In bladder cancer, particularly non-muscle-invasive disease, this tissue harbors tumors that require removal to prevent progression. Physical ablation techniques, such as transurethral resection of bladder tumor (TURBT), high-intensity focused ultrasound (HIFU), laser ablation, or radiofrequency ablation, are employed to destroy or excise abnormal superficial tissue while preserving bladder function. These methods achieve targeted tissue necrosis through mechanical resection, thermal energy, or focused ultrasound, creating sharply delineated ablation zones without widespread collateral damage. TURBT, the standard initial approach, uses an electrified loop via cystoscope to resect tumors for diagnosis and treatment, often followed by cauterization to control bleeding. Experimental laparoscopic extravesical HIFU enables transmural ablation of superficial tumors in intact bladders, suitable for select muscle-invasive cases desiring bladder preservation. While effective for superficial lesions, challenges include risks of bleeding, infection, and incomplete resection, with healing involving inflammation, granulation, and fibrosis over weeks to months. This tissue is not a molecular therapeutic target like a receptor or enzyme but a surgical site for focal therapy in bladder cancer management.

Other names

Bladder wall tissueSuperficial bladder tissueUrothelium and submucosa